undamentalytics Newsletter
Sign in

Bio Green Med Solution, Inc. cash flow statement

In fiscal 2025, Bio Green Med Solution, Inc.'s operations generated −$4.8m of cash; it spent $0 on capital projects, leaving free cash flow of −$4.8m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−15−16−14−12−18−19−14−10−7−7−8−19−21−16−8−5−1
Depreciation and amortisation100000003200000000
Stock-based pay12100111000121121
Capital spending00000000000000000
Free cash flow−15−16−14−12−18−19−14−10−7−7−8−19−21−16−8−5−1
Free cash flow after stock pay−16−18−15−12−19−20−15−11−8−7−8−20−22−18−9−7−2
Shares issued43942812117151304—1662

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BGMS vs CTNTBGMS vs INEOBGMS vs YDDL

More: Distributors stocks compared, Consumer Discretionary sector, rankings of US companies

Figures from Bio Green Med Solution, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bio Green Med Solution, Inc.